COMPARISON TOOL

Compare peptides

Half-life, dosing, mechanism, status — side by side. Select up to four compounds, or start from a preset.

Tirzepatide

Max 4 peptides

Property	Tirzepatide
Category	GLP-1
Type	Peptide
Mechanism	Dual GIP / GLP-1 receptor agonist
Status	FDA-approved
Dosing range	2.5–15 mg weekly
Frequency	Once weekly
Half-life	~5 days
Route	Subcutaneous
Onset	1–4 weeks for appetite reduction
Studied for	Weight management Type 2 diabetes Appetite control
Key risks	Nausea Vomiting Diarrhea Constipation
Storage	Refrigerated (2–8 °C); use within the pharmacy beyond-use date
Available at G1	Not currently carried. Ask a provider
Tools	Dosage calculator →

PROPERTY COMPARISON · RADAR

Editorial profile scores (0–10) for orientation — not clinical measurements.

TYPICAL DOSE RANGES

Tirzepatide2.5 mg – 15 mg

Typical per-dose range on a logarithmic scale. Your provider sets your dose.

For educational purposes only. Consult a licensed provider before starting any peptide protocol.